Cover
Cover - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Mar. 24, 2022 | Jun. 30, 2021 | |
Document Type | 10-K/A | ||
Amendment Flag | false | ||
Document Annual Report | true | ||
Document Transition Report | false | ||
Document Period End Date | Dec. 31, 2021 | ||
Document Fiscal Period Focus | FY | ||
Document Fiscal Year Focus | 2021 | ||
Current Fiscal Year End Date | --12-31 | ||
Entity File Number | 001-38302 | ||
Entity Registrant Name | NRX PHARMACEUTICALS, INC. | ||
Entity Central Index Key | 0001719406 | ||
Entity Tax Identification Number | 82-2844431 | ||
Entity Incorporation, State or Country Code | DE | ||
Entity Address, Address Line One | 1201 Orange Street | ||
Entity Address, Address Line Two | Suite 600 | ||
Entity Address, City or Town | Wilmington | ||
Entity Address, State or Province | DE | ||
Entity Address, Postal Zip Code | 19801 | ||
City Area Code | 484 | ||
Local Phone Number | 254-6134 | ||
Entity Well-known Seasoned Issuer | No | ||
Entity Voluntary Filers | No | ||
Entity Current Reporting Status | Yes | ||
Entity Interactive Data Current | Yes | ||
Entity Filer Category | Non-accelerated Filer | ||
Entity Small Business | true | ||
Entity Emerging Growth Company | true | ||
Elected Not To Use the Extended Transition Period | true | ||
Entity Shell Company | false | ||
Entity Public Float | $ 187.3 | ||
Entity Common Stock, Shares Outstanding | 66,641,314 | ||
ICFR Auditor Attestation Flag | false | ||
Auditor Name | KPMG LLP | ||
Auditor Location | Short Hills, NJ | ||
Auditor Firm ID | 185 | ||
Common Stock [Member] | |||
Title of 12(b) Security | Common Stock, par value $0.001 per share | ||
Trading Symbol | NRXP | ||
Security Exchange Name | NASDAQ | ||
Common Stock warrants [Member] | |||
Title of 12(b) Security | Warrants to purchase one share of Common Stock | ||
Trading Symbol | NRXPW | ||
Security Exchange Name | NASDAQ |